Journal Title：Current Cancer Drug Targets

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes.

Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer.

As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

《當前癌癥藥物靶點》旨在涵蓋與癌癥有關的當代分子藥物靶點的藥物化學、藥理學、分子生物學、基因組學和生物化學方面的所有最新和杰出進展，例如疾病特異性蛋白質、受體、酶和基因。

《當前癌癥藥物靶點》發(fā)表原創(chuàng)研究文章、信件、評論/小評論、藥物臨床試驗研究和客座編輯專題，由該領域的領導者撰寫，涵蓋與癌癥有關的一系列藥物靶點的當前主題。

隨著抗癌藥物發(fā)現(xiàn)的新型人類藥物靶點的發(fā)現(xiàn)、鑒定、表征和驗證不斷增長；這本期刊已成為所有參與藥物發(fā)現(xiàn)和開發(fā)的制藥科學家的必讀讀物。

Current Cancer Drug Targets創(chuàng)刊于2001年，由Bentham Science Publishers B.V.出版商出版，收稿方向涵蓋醫(yī)學 - 腫瘤學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業(yè)影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發(fā)表機率較高。平均審稿速度 約1月 ，影響因子指數(shù)2.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。